Each DxBook includes information on testing infrastructure, kits and reagents, volumes, and future trends. Historical data is available for all DxBooks, and data collection is ongoing for the ID DxBook and NGS Oncology DxBook.
Our most established DxBook, available since 2016, surveying labs on 31 infectious disease analytes
Our newest but most granular DxBook, uncovering insights about Therapy Selection and MRD testing.
Single-biomarker Oncology DxBook (focused on IHC testing) and the SARS-CoV-2 DxBook, documenting lab evolution throughout the pandemic
